This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Top Research Reports for April 5, 2017
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Aetna (AET), BHP Billiton (BHP) and Sprint (S).
Teladoc to Boost Jefferson Health's Telehealth Platform
by Zacks Equity Research
Teladoc's (TDOC) services will complement JeffConnect, the telehealth program of Jefferson Health.
Is Anthem (ANTM) About to Exit Public Exchange Business?
by Zacks Equity Research
Anthem Inc. (ANTM) is planning to scale back its participation on loss making public exchange business for 2018, as per analysts who met management.
Renewed Obamacare Repeal Effort Sends Hospital Stocks Down
by Benjamin Rains
Hospital stocks have dipped again amid reports that House Republicans will continue to pursue their health care reform plan in 2017.
ETFs Deserving a Close Watch If Health Care Plans Fail
by Sanghamitra Saha
With Trump's Health Care plans, due for voting today, these ETFs may see considerable movement.
4 Reasons Why UnitedHealth (UNH) Stock Looks Attractive Now
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) remains the leader in the health insurance industry by virtue of its vast scale and tremendously diversified operations.
Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
by Zacks Equity Research
Molina Healthcare Inc. (MOH) continues to suffer from ongoing issues related to the Affordable Care Act's insurance Marketplace.
Humana Poised to Grow on Government Business, Strong Capital
by Zacks Equity Research
Humana, Inc. (HUM) stock has long been an investor favorite owing to its strong fundamentals.
Should Value Investors Consider Aetna (AET) Stock?
by Zacks Equity Research
Is Aetna a great pick from the value investor's perspective right now? Read on to know more.
Will Health Insurers Win Under Obamacare Replacement Plan?
by Zacks Equity Research
While retaining the pre-existing conditions clause might hinder health insurers' business, their ability to charge a penalty on those who fail to maintain coverage is being seen as a positive.
Trump Promises Interstate Coverage Sales, Will It Help Insurance Stocks?
by Ryan McQueeney
Just a day after Republicans unveiled their highly-anticipated plan to repeal and replace Obamacare, President Donald Trump has taken to Twitter to promise that one key provision--eliminating state lines for insurance sales--will come at a later phase in the healthcare rollout.
Teladoc (TDOC) Q4 Loss Lower Than Expected, Guides for '17
by Zacks Equity Research
Teladoc Inc.'s (TDOC) fourth-quarter operating loss of 31 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 35 cents per share.
Select Medical (SEM) Q4 Earnings Miss, Keeps 2017 Guidance
by Zacks Equity Research
Select Medical Holdings Corp. (SEM) reported fourth-quarter 2016 earnings of 12 cents per share, which missed the Zacks Consensus Estimate by a couple of cents.
Tenet Healthcare (THC) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Tenet Healthcare Corp. (THC) reported fourth-quarter 2016 operating earnings of 6 cents per share that missed the Zacks Consensus Estimate of 20 cents by 70%.
5 Stocks to Buy for the Post-Obamacare Era
by Swarup Gupta
Insurers, hospitals and healthcare service providers with strong fundamentals would make welcome additions to your portfolio.
Community Health Systems (CYH) Q4 Earnings Beat Estimates
by Zacks Equity Research
Community Health Systems, Inc. (CYH) reported adjusted earnings of 46 cents per share in the fourth quarter of 2016, which crushed the Zacks Consensus Estimate of 12 cents by 283%
Moody's Jumps into Action as Aetna-Humana Deal Fails
by Zacks Equity Research
After the merger deal between Aetna Inc. (AET) and Humana Inc. (HUM) fell through, rating agency Moody's Investors Service jumped into action
Molina Healthcare (MOH) Q4 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Molina Healthcare Inc. (MOH) reported fourth-quarter 2016 adjusted net income per share of 63 cents, missing the Zacks Consensus Estimate of 75 cents by 16%.
Cigna-Anthem Merger Conflict Continues with Countersuit
by Zacks Equity Research
Cigna (CI)-Anthem (ANTM) fight has reached a stage where the focus is on the breakup fee and damages rather than the sealing of the deal.
Health Insurers' Courtship Ends on Valentine's Day
by Zacks Equity Research
More than one and a half years of courtship between Anthem Inc. (ANTM) and Cigna Corp. (CI) as well as Aetna Inc. (AET) and Humana Inc. (HUM) ended yesterday.
Cigna Wants Divorce from Anthem Deal, Sues for Nearly $15 Billion
by Madeleine Johnson
On the heels of Aetna's (AET) and Humana's (HUM) announcement, health insurance competitors Cigna (CI) and Anthem (ANTM) also announced that their merger deal is done-zo on Tuesday.
Stock Market Roundup, Feb. 14: Stocks Spread the Love on Valentine's Day
by Ryan McQueeney
Valentine's Day is not everyone???s favorite holiday, but investors should be pleased either way after a relatively solid day on the stock market.
Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
by Madeleine Johnson
On Tuesday, health insurance giants Aetna (AET) and Humana (HUM) announced that they have called off their merger agreement after a federal court decision struck down the deal as anticompetitive.
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
Anthem-Cigna Merger Receives a Blow from Federal Judge
by Zacks Equity Research
As anticipated, the merger between Anthem Inc. (ANTM) and Cigna Corp. (CI) saw the same fate as that of Aetna and Humana which was blocked last month.